Clostridium difficile infection: review.
Authors of this article are:
Czepiel J, Dróżdż M, Pituch H, Kuijper EJ, Perucki W, Mielimonka A, Goldman S, Wultańska D, Garlicki A, Biesiada G.
A summary of the article is shown below:
Clostridium difficile (C. difficile) is a Gram-positive, spore-forming, anaerobic bacillus, which is widely distributed in the intestinal tract of humans and animals and in the environment. In the last decade, the frequency and severity of C. difficile infection has been increasing worldwide to become one of the most common hospital-acquired infections. Transmission of this pathogen occurs by the fecal-oral route and the most important risk factors include antibiotic therapy, old age, and hospital or nursing home stay. The clinical picture is diverse and ranges from asymptomatic carrier status, through various degrees of diarrhea, to the most severe, life threatening colitis resulting with death. Diagnosis is based on direct detection of C. difficile toxins in feces, most commonly with the use of EIA assay, but no single test is suitable as a stand-alone test confirming CDI. Antibiotics of choice are vancomycin, fidaxomicin, and metronidazole, though metronidazole is considered as inferior. The goal of this review is to update physicians on current scientific knowledge of C. difficile infection, focusing also on fecal microbiota transplantation which is a promising therapy.
Check out the article’s website on Pubmed for more information:
This article is a good source of information and a good way to become familiar with topics such as: Antibiotic-associated diarrhea;Clostridium difficile;Diagnosis;Fecal transplantation;Treatment.
New Chemicals from MOLECULAR DEPOT
Triglyceride Mix for Interference Testing
Microparticle Stabilizer Solution
Enzyme Acceptor Stabilization Buffer
Enzyme Donor Stabilization Buffer
Progesterone Biotin Conjugate Solution
Microparticle Activation Buffer
Microparticle Washing Buffer
Microparticle Blocking Buffer
Microparticle Anti Aggregation Agent
CPRG (Chlorophenol red-β-D-galactopyranoside)
New Antibodies from MOLECULAR DEPOT
Antibody to Thyroxine T4 Monoclonal
SAA Antibody Monoclonal Anti-Serum Amyloid A
Valproic Acid Antibody (Mouse Monoclonal)
Phenytoin Antibody (Mouse Monoclonal)
Anti Sheep IgG (H+L) Rabbit Polyclonal
Anti Human IgM Antibody Polyclonal
Myoglobin Antibody (Human Affinity Purified)
Rheumatoid Factor Interference Blocker
HAMA Blocking Reagent (Affinity Purified)
New Proteins from MOLECULAR DEPOT
Tacrolimus BSA Conjugate Solution
Cholesterol Oxidase from Streptomyces sp.
Aprotinin from Bovine Lung (Lyophilized powder)
Beta-galactosidase Enzyme Donor
Beta-galactosidase Enzyme Acceptor
Xanthine Oxidase Grade II (Lyophilized Powder)
Ascorbate Oxidase (Lyophilized Powder)
Silk Fibroin (Bombyx Mori Silkworm)
Fibrinogen from Bovine Plasma Lyophilized
Horseradish Peroxidase Biotinylated
New Research Kits from MOLECULAR DEPOT
Interference Test Kit
Alpha Complementation Kit Beta-galactosidase
Crystallization Screen for Protein-DNA Complexes
NativeFolder Bacterial Culture Medium
CycloScreen: Cyclodextrins Kit for Screening
NativePro Bradford Protein Assay Kit (Automated)
Rheumatoid Factor Interference Kit
Interference Test Kit EXTRA
HAMA Interference Kit
ELISA Microplate Production Kit